from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0320/-

LFCtreatmentdescriptionclass of inhibitor

-0.911

Amikacinug/mL Amikacintranslation

-0.667

Cap5-10ug/mL Capreomycintranslation

-1.193

Rox10-50 ug/mL Roxithromycintranslation

-0.383

SM2-5 ug/mL Streptomycintranslation

-1.829

Tet5-10 ug/mL Tetracyclinetranslation

0.317

Rif0.2-5ug/mL Rifampicintranscription

1.099

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.343

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.549

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.158

CPZ10-50 ug/mL Chlorpromazinerespiration

0.375

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.336

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.971

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.346

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.804

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.468

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.858

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.217

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.454

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.162

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.640

KCN5-20 ug/mL Potassium cyaniderespiration

-1.009

NaN30.2-2 mM Sodium aziderespiration

-1.285

Nigericin50 uM Nigericinrespiration

0.649

TRC10-150 ug/mL Triclosanrespiration

0.834

TRZ10-25 ug/mL Thioridazinerespiration

-1.913

Valinomycin0.5-10 uM Valinomycinrespiration

-2.645

ZnSO42 mM ZnSO4respiration

-0.048

menadione6-10 ug/mL Menadionerespiration

0.350

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.055

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.183

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.288

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.380

NRP_1Non-replicating persistence stage 1dosRassociated

0.519

Amp0.2mg/mL AmpicillincellWall

-0.299

Cephalexin20-100 ug/mL CephalexincellWall

-0.326

Cerulenin0.32-5 ug/mL CerulenincellWall

0.333

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.002

EMB10-20 ug/mL EthambutolcellWall

-0.875

Eta12-40 ug/mL EthionamidecellWall

-1.103

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.157

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.747

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.247

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.530

BZA0.12 mg/mL BenzamidearomaticAmides

0.446

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.069

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.070

H2O24 mM hydrogen peroxideDNAdamaging

0.082

Levo10 ug/mL LevofloxacinDNAdamaging

0.584

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.417

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.174

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.094

UVUV-irradiationDNAdamaging

0.845

ARP41-4 ug/mL Antitubercular compound ARP4?

0.024

Antimycin12.5-50 ug/mL Antimycin A?

-0.791

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.301

PA_110-50 ug/mL Antitubercular compound PA-1?

0.422

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.473

PA8240.2-2 ug/mL PA-824?

-0.029

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.167

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.268

Verapamil50 uM Verapamil?

-0.071

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.433

methoxatin10-20 ug/mL Methoxatin?